Table 6. Clinical and epidemiological characteristics of virus positive and negative patients < 5 years.
| Variable | Virus Positive (n = 14) | Virus Negative (n = 22) | p value |
|---|---|---|---|
| Median Age in Years (range +- SD) | 2.3 (0.3–4.9; +-1.3) | 2.6 (0.3–4.3; +-1.2) | 0.29a |
| Clinical and Radiological Features | |||
| Change in sinus discharge | 12 (85.7%) | 13 (59.1%) | 0.14 |
| Worsening cough | 14 (100%) | 22 (100%) | 1 |
| Change in sputum pattern | 11 (78.6%) | 15 (68.2%) | 0.71 |
| Worsening dyspnea | 9 (64.3%) | 16 (72.7%) | 0.72 |
| Hemoptysis | 0 | 0 | 1 |
| Fatigue | 6 (42.9%) | 3 (13.6%) | 0,11 |
| Fever | 9 (64.3%) | 5 (22.7%) | 0,01 |
| Anorexia / weight loss | 8 (57.1%) | 11 (50%) | 0,68 |
| Oxygen therapy | 4 (8.6%) | 7 (31.8%) | 1 |
| Abnormal Chest Auscultation | 13 (92.9%) | 21 (95.4%) |  |
| Hospital Admission | 6 (42.9%) | 10 (45.4%) |  |
| Severity Scores | |||
| CFCSb (mean) | 30.3 (19–38; +-5.7) | 28.1 (19–37; +-4.4) | 0.12a |
| Mean Shwachman-Kulczycki Score (range +- SD) | 78.2 (65–95; +-8.5) | 76.4 (60–90: +-7.4) | 0.25 a |
aStudent’s T test.
bCystic Fibrosis Clinical Score.